The estimated Net Worth of Associates, L.L.C.Caxton Co... is at least $48.5 Million dollars as of 17 September 2020. Associates Co owns over 1,479,377 units of Kala Bio stock worth over $48,525,306 and over the last 7 years Associates sold KALA stock worth over $0.
Associates has made over 9 trades of the Kala Bio stock since 2017, according to the Form 4 filled with the SEC. Most recently Associates bought 1,479,377 units of KALA stock worth $3,328,598 on 17 September 2020.
The largest trade Associates's ever made was buying 1,479,377 units of Kala Bio stock on 17 September 2020 worth over $3,328,598. On average, Associates trades about 287,765 units every 116 days since 2017. As of 17 September 2020 Associates still owns at least 8,060,682 units of Kala Bio stock.
You can see the complete history of Associates Co stock trades at the bottom of the page.
Over the last 7 years, insiders at Kala Bio have traded over $2,579,128 worth of Kala Bio stock and bought 23,705,318 units worth $209,975,371 . The most active insiders traders include Capital Management, L.P.Ra ..., Capital Management, L.P.Ra ..., and Rajeev M. Shah. On average, Kala Bio executives and independent directors trade stock every 31 days with the average trade being worth of $2,090,132. The most recent stock trade was executed by Todd Bazemore on 26 June 2024, trading 4,653 units of KALA stock currently worth $22,102.
kala pharmaceuticals, inc. (kala) is a biopharmaceutical company focused on the development and commercialization of therapeutics using our proprietary nanoparticle-based mucus penetrating particles, or mpp, technology, with an initial focus on the treatment of eye diseases. for more information, please visit kala’s website at www.kalarx.com.
Kala Bio executives and other stock owners filed with the SEC include: